#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Plasma cell myeloma Metastatic malignant melanoma Frontotemporal dementia Pulmonary arterial hypertension Astrocytoma malignant Porphyria non-acute Skin angiosarcoma Congenital aplastic anaemia Acute myeloid leukaemia (in remission) Basal cell naevus syndrome Neuropathic arthropathy Oesophageal atresia Immunodeficiency Isodicentric chromosome 15 syndrome Neuroendocrine tumour More trials…

    Learn about Rare Diseases

    Choroid melanoma Stevens-Johnson syndrome – Life with Disease Arterial tortuosity syndrome – Trials in Disease Kearns-Sayre syndrome Malignant fibrous histiocytoma – Basic Information Hairy cell leukaemia – Life with Disease Carcinoid syndrome – Treatment Mastocytosis – Basic Information Aicardi-Goutieres syndrome – Diagnostics Hereditary hypophosphataemic rickets – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ALXN1920 Naloxone Hydrochloride Immunglobulin Nicotinamide Alfacalcidol Bevacizumab Zirconium Zr-89 Navitoclax Mercaptamine Lactulose Ropivacaine Hydrochloride Paliperidone Alclometasone Dipropionate GSK4418959A ALLERGEN EXTRACTS ATIGOTATUG TUVATEXIB Volrustomig Mepolizumab Remifentanil Hydrochloride Immunoglobulin A More therapies…

    Learn about Your Condition

    Radiation skin injury Conjunctivitis Fungal infection Hepatotoxicity Normal pressure hydrocephalus Gout Metabolic surgery Cutaneous calcification Peripheral ischaemia Pseudomyxoma peritonei Infective uveitis Vaginal haemorrhage Nephrogenic anaemia Acromegaly Alcoholic liver disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Bp 96031, Rouen, 76031, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Rituximab, Prednisolone and Betamethasone in Adult Patients with First Episode of Minimal Change Nephrotic Syndrome to Prevent Disease Relapse

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Nephrotic syndrome
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Prednisolone
    • Rituximab
    France

  • Study on the Effects of Dapagliflozin on Blood Vessel Health in Patients with Chronic Kidney Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Dapagliflozin
    France

  • Study on Bezafibrate for Patients with Primary Sclerosing Cholangitis and Persistent Cholestasis Despite Ursodeoxycholic Acid Therapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Bezafibrate
    France

  • Study on Sotatercept for Treating Pulmonary Hypertension in Adults with Heart Failure

    Not recruiting

    2 1
    Investigated Diseases:
    • Pulmonary hypertension
    Investigated Drugs:
    • Sotatercept
    Belgium France Germany Italy Poland Spain +1

  • Study on the Effects of Methylprednisolone and Placebo on Ventilator Support Duration in Severe COPD Patients in Intensive Care

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Methylprednisolone Hydrogen Succinate
    • Sodium Chloride
    France

  • Study on Nicotinamide for Preventing Kidney Problems in Septic Shock Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Septic shock
    Investigated Drugs:
    • Nicotinamide
    • Sodium Chloride
    France

  • Study on Dexamethasone for Patients with Herpes Simplex Virus Encephalitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Human herpesvirus 6 encephalitis
    Investigated Drugs:
    • Dexamethasone
    France

  • Study on Infliximab and Tocilizumab for Patients with Refractory or Relapsing Takayasu Arteritis

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Infliximab
    • Tocilizumab
    France

  • Study on Imlifidase for Highly Sensitized Patients with End-Stage Chronic Kidney Disease Awaiting Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Kidney transplant rejection
    Investigated Drugs:
    • Imlifidase
    Austria Belgium Czechia France Germany Italy +4

  • Study on the Long-Term Safety and Effectiveness of Nemolizumab for Patients with Prurigo Nodularis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Neurodermatitis
    Investigated Drugs:
    • Nemolizumab
    Austria Belgium Denmark France Germany Hungary +5
Previous Page
1 … 33 34 35 36 37 … 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!